Scientists fear that existing genetic techniques will be misused before the consequences of altering the human blueprint on personal, generational, and societal levels are fully realized. At St. Jude Children’s Research Hospital in Memphis, Tennessee,
Scientists fear that existing genetic techniques will be misused before the consequences of altering the human blueprint on personal, generational, and societal levels are fully realized. At St. Jude Childrens Research Hospital in Memphis, Tennessee, leading ethicists and genetic experts argued that our current ability to manipulate our genes brings with it an obligation to conduct a worldwide discourse, which has not occurred to date.
Sometimes, as a society, we see what we want to see in technology and fail to look at the down side, said W. French Anderson, MD, director of Gene Therapy Laboratories at the University of Southern California, School of Medicine. With something like genetic screening for cancer, the same technology that gives us the ability to eradicate deadly disease carries with it a great potential for misuse.
Misuse May Lead to Loss of Humanness
Dr. Anderson also discussed the difference between treatment (using genetic therapy to cure disease) and enhancement (using genetic therapy to create genetically superior humans). He cautioned that genetic engineering may alter our humanness.
Dr. Andersons colleague, Eric Juengst, PhD, associate professor of biomedical ethics at Case Western Reserve University School of Medicine and a member of the Committee on Human Genome Diversity of the National Research Council, warned that the problem with enhancement is that it corrupts an individuals ability to honestly achieve a goal.
We need to have fair competition in society, said Dr. Juengst. Getting top grades, or pole vaulting with pharmaceutical help is cheatingand exclusionary based on cost.
The countrys leading legal and theological experts and top cancer researchers convened recently to discuss these and other moral, ethical, religious, and scientific questions at the Ethical Boundaries in Cancer Genetics symposium hosted by St. Jude.
Alzheimer Disease Awareness Month 2024: Looking Back at a Year of Progress in Cell and Gene Therapy
November 24th 2024In observance of Alzheimer Disease Awareness Month, held annually in November, we took a look back at the past year's news and expert insights in cell and gene therapy for Alzheimer disease.
Evaluating Allogeneic CAR-T P-BCMA-ALLO1 in R/R Multiple Myeloma
November 21st 2024Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center, discussed interim data from the phase 1/1b clinical trial evaluating Poseida's CAR-T.